- Home
- COLL vs OXM Comparison
COLL vs OXM Comparison
Compare COLL & OXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- OXM
- Stock Information
- Founded
- COLL 2002
- OXM 1942
- Country
- COLL United States
- OXM United States
- Employees
- COLL N/A
- OXM N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- OXM Apparel
- Sector
- COLL Health Care
- OXM Consumer Discretionary
- Exchange
- COLL Nasdaq
- OXM Nasdaq
- Market Cap
- COLL 910.2M
- OXM 958.1M
- IPO Year
- COLL 2015
- OXM N/A
- Fundamental
- Price
- COLL $29.05
- OXM $54.76
- Analyst Decision
- COLL Strong Buy
- OXM Hold
- Analyst Count
- COLL 5
- OXM 5
- Target Price
- COLL $43.60
- OXM $66.50
- AVG Volume (30 Days)
- COLL 438.9K
- OXM 563.3K
- Earning Date
- COLL 05-08-2025
- OXM 03-27-2025
- Dividend Yield
- COLL N/A
- OXM 5.00%
- EPS Growth
- COLL 43.56
- OXM 53.66
- EPS
- COLL 1.86
- OXM 5.87
- Revenue
- COLL $631,449,000.00
- OXM $1,516,601,000.00
- Revenue This Year
- COLL $20.00
- OXM $3.65
- Revenue Next Year
- COLL $3.93
- OXM $2.74
- P/E Ratio
- COLL $15.63
- OXM $10.37
- Revenue Growth
- COLL 11.41
- OXM N/A
- 52 Week Low
- COLL $27.28
- OXM $53.23
- 52 Week High
- COLL $42.29
- OXM $111.46
- Technical
- Relative Strength Index (RSI)
- COLL 43.65
- OXM 32.85
- Support Level
- COLL $29.01
- OXM $58.06
- Resistance Level
- COLL $30.53
- OXM $61.02
- Average True Range (ATR)
- COLL 0.88
- OXM 2.90
- MACD
- COLL -0.01
- OXM 0.22
- Stochastic Oscillator
- COLL 20.97
- OXM 13.71
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About OXM Oxford Industries Inc.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates a majority of its revenue from the Tommy Bahama division.